The Mammomat Inspiration Prime Edition lowers dose by replacing the standard scatter radiation grid with a new algorithm for progressive image reconstruction. This new algorithm identifies scatter-causing structures and calculates a corrected image, enabling complete use of primary radiation so physicians can achieve high-quality images with less dose. The development of innovative products like the digital full-field Mammomat Inspiration is a goal of the Siemens Healthcare Sector's global "Agenda 2013" initiative.
In digital X-ray breast imaging, radiation passes through the examined breast to a detector. Primary radiation supplies the information needed to produce the X-ray image, while scattered radiation is absorbed by special grids positioned between the breast and the detector. Unfortunately, these scatter grids also absorb part of the all-important primary radiation, forcing physicians to use a higher dose to obtain images of desired quality. Since mammography means regular screening of healthy women, minimizing dose is extremely important.
Siemens' new reconstruction algorithm for the Mammomat Inspiration system – known as Prime (Progressive Reconstruction, Intelligently Minimizing Exposure) – eliminates the need for the conventional scatter radiation grid. The Prime algorithm subsequently corrects the scattered radiation by identifying scatter-causing structures and recalculating the image. The primary radiation that radiologists rely upon remains intact. Therefore, a grid is no longer necessary, and lower doses are sufficient to produce high-quality images. The grid-free imaging technology of the Mammomat Inspiration Prime Edition can reduce radiation dose up to 30 percent compared to its predecessor model, depending on the thickness of the patient's breast tissue.
Shipping the first quarter of 2013, the Mammomat Inspiration Prime Edition is based on the modular Mammomat Inspiration platform for screening, diagnostics, biopsy, and tomosynthesis used by hospitals and physicians' offices since 2007. Facilities have the option of purchasing the basic equipment, upgrading biopsy or tomosynthesis later as the need arises.
The software-driven Mammomat Inspiration Prime Edition demonstrates the innovative power of Siemens Healthcare and meets a goal of the global "Agenda 2013" initiative, which the Siemens Healthcare Sector unveiled in November 2011. The initiative defines plans of action to be implemented within two years in the areas of innovation, competitiveness, regional presence, and human resource development.
The Siemens Healthcare Sector is one of the world's largest suppliers to the healthcare industry and a trendsetter in medical imaging, laboratory diagnostics, medical information technology and hearing aids. Siemens offers its customers products and solutions for the entire range of patient care from a single source – from prevention and early detection to diagnosis, and on to treatment and aftercare. By optimizing clinical workflows for the most common diseases, Siemens also makes healthcare faster, better and more cost-effective. Siemens Healthcare employs some 51,000 employees worldwide and operates around the world. In fiscal year 2012 (to September 30), the Sector posted revenue of 13.6 billion euros and profit of 1.8 billion euros. For further information please visit: http://www.siemens.com/healthcare
The products mentioned here are not commercially available in all countries. Due to regulatory reasons the future availability in any country cannot be guaranteed. Further details are available from the local Siemens organizations.
Tomosynthesis is not available in the U.S.
Reference Number: HCP201211004eContact
Kathrin Schmich | Siemens Healthcare
Gentle sensors for diagnosing brain disorders
29.09.2016 | King Abdullah University of Science and Technology
New imaging technique in Alzheimer’s disease - opens up possibilities for new drug development
28.09.2016 | Lund University
Ultrafast lasers have introduced new possibilities in engraving ultrafine structures, and scientists are now also investigating how to use them to etch microstructures into thin glass. There are possible applications in analytics (lab on a chip) and especially in electronics and the consumer sector, where great interest has been shown.
This new method was born of a surprising phenomenon: irradiating glass in a particular way with an ultrafast laser has the effect of making the glass up to a...
Terahertz excitation of selected crystal vibrations leads to an effective magnetic field that drives coherent spin motion
Controlling functional properties by light is one of the grand goals in modern condensed matter physics and materials science. A new study now demonstrates how...
Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.
"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...
In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.
A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...
By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.
"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...
14.10.2016 | Event News
14.10.2016 | Event News
12.10.2016 | Event News
27.10.2016 | Materials Sciences
27.10.2016 | Physics and Astronomy
27.10.2016 | Life Sciences